Hostname: page-component-78c5997874-s2hrs Total loading time: 0 Render date: 2024-11-17T18:08:54.186Z Has data issue: false hasContentIssue false
  • English
  • Français

A Cluster of Methicillin-Susceptible Staphylococcus aureus Infections at a Rheumatology Practice, New York City, 2011

Published online by Cambridge University Press:  10 May 2016

Kate Drezner ,
Mike Antwi ,
Paula Del Rosso ,
Marie Dorsinville ,
Pamela Kellner  and
Joel Ackelsberg
Kate Drezner*
Affiliation:
New York City Department of Health and Mental Hygiene, Bureau of Communicable Disease, Queens, New York
Mike Antwi
Affiliation:
New York City Department of Health and Mental Hygiene, Bureau of Communicable Disease, Queens, New York
Paula Del Rosso
Affiliation:
New York City Department of Health and Mental Hygiene, Bureau of Communicable Disease, Queens, New York
Marie Dorsinville
Affiliation:
New York City Department of Health and Mental Hygiene, Bureau of Communicable Disease, Queens, New York
Pamela Kellner
Affiliation:
New York City Department of Health and Mental Hygiene, Bureau of Communicable Disease, Queens, New York
Joel Ackelsberg
Affiliation:
New York City Department of Health and Mental Hygiene, Bureau of Communicable Disease, Queens, New York
*
Philadelphia Department of Public Health, 500 South Broad Street, Philadelphia, PA 19146 (katherine.drezner@phila.gov)
Get access Rights & Permissions [Opens in a new window]

Abstract

A cluster of 5 methicillin-susceptible Staphylococcus aureus infections occurred after administration of methylprednisolone acetate injections in a rheumatology practice. A site visit was conducted to inspect examination rooms, observe techniques, and review charts. The investigation revealed a pervasive lack of aseptic technique that led to multiple opportunities for medication contamination.

Type
Concise Communication
Information
Infection Control & Hospital Epidemiology , Volume 35 , Issue 2 , February 2014 , pp. 187 - 189
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2014

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

a

Present Affiliation: Philadelphia Department of Public Health, Philadelphia, Pennsylvania

References

1. Perz, JF, Thompson, ND, Schaefer, MK, Patel, PR. US outbreak investigations highlight the need for safe injection practices and basic infection control. Clin Liver Dis 2010;14:137–151.CrossRefGoogle ScholarPubMed
2. Radcliffe, R, Meites, E, Briscoe, J, et al. Severe methicillin-susceptible Staphylococcus aureus infections associated with epidural injections at an outpatient pain clinic. Am J Infect Control 2012;40:144–149.CrossRefGoogle ScholarPubMed
3. Invasive Staphylococcus aureus infections associated with pain injections and reuse of single-dose vials-Arizona and Delaware, 2012. MMWR Morb Mortal Wkly Rep 2012;61:501–504.Google Scholar
4. Kim, HY, Yun, YJ, Park, CG, et al. Outbreak of Mycobacterium masstliense infection associated with intramuscular injections. J Clin Microbiol 2007;45(9):3127.Google Scholar
5. Guh, AY, Thompson, ND, Schaefer, MK, Patel, PR, Perz, JF. Patient notification for bloodborne pathogen testing due to unsafe injection practices in the US health care settings, 2001-2011. Med Care 2012;50(9):785–791.Google Scholar
6. Centers for Disease Control and Prevention. Guide to infection prevention for outpatient settings: minimum expectations for safe care. 2011. http://www.cdc.gov/HAI/pdfs/guidelines/standatds-of-ambulatory-care-7-2011.pdf. Accessed July 17, 2012.Google Scholar
7. Tenover, F, Vaughn, RR, McDougal, LK, et al. Multiple-locus variable-number tandem-repeat assay analysis of methicillin-resistant Staphylococcus aureus strains. J Clin Micro 2007;45: 2215–2219.CrossRefGoogle ScholarPubMed
8. New York State Department of Health. New York Public Health Law §239. Accessed October 1, 2013. http://www.health.ny.gov /regulations/public_health_law/section/239/.Google Scholar
9. Siegel, JD, Rhinehart, E, Jackson, M, Chiarello, L; Centers for Disease Control and Prevention; Healthcare Infection Control Practices Advisory Committee. 2007. 2007 guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings, http://www.cdc.gov/hicpac/pdf/isolation/Isolation2007.pdf. Accessed March 7, 2013.Google Scholar
10. Occupational Safety and Health Administration (OSHA). Bloodborne pathogens. 2012. http://www.osha.gov/pls/oshaweb/owadisp.show_document?p_table=standards&p_id=10051. Accessed August 13, 2013.Google Scholar